SN5
SHORT NOTE
5M
★ High-yield
Describe carcinoma of the urinary bladder with its aetiology, morphology and clinical features.
Introduction
Urothelial (transitional cell) carcinoma accounts for over 90% of bladder tumours, and may arise anywhere the urothelium is found — renal pelvis, ureter, bladder and proximal urethra.
- Male to female ratio about 3:1; usually over 50
- A "field change" disease — the whole urothelium is exposed to the same carcinogens, so tumours are frequently multifocal and recurrent, which dictates lifelong surveillance
Aetiology
| Factor | Detail |
|---|---|
| Smoking | The single greatest risk, responsible for about half of cases; a three- to sevenfold increase |
| Occupational aromatic amines | Beta-naphthylamine and benzidine — aniline dye, rubber, leather, printing and textile industries; latency of 15 to 40 years |
| Schistosoma haematobium | Chronic infestation causes squamous metaplasia and then squamous cell carcinoma; important in Egypt and parts of Africa |
| Chronic irritation | Long-term catheterisation, bladder stones, recurrent infection — also predispose to squamous carcinoma |
| Drugs and radiation | Cyclophosphamide (through acrolein, which also causes haemorrhagic cystitis), phenacetin abuse, pelvic radiotherapy |
| Other | Bladder exstrophy (adenocarcinoma); urachal remnants (adenocarcinoma) |
Morphology and Behaviour
| Category | Features | Behaviour |
|---|---|---|
| Papillary non-invasive (low grade) | Delicate branching fronds with a fibrovascular core; orderly urothelium | Recurs often but rarely invades; good prognosis |
| Papillary high grade | Disordered, pleomorphic urothelium with mitoses at all levels | Significant risk of invasion |
| Carcinoma IN situ (flat) | Flat, high-grade dysplasia with no papillary structure; may look like harmless erythema or be invisible cystoscopically | High risk of progression to invasive disease — far more dangerous than its appearance suggests |
| Invasive | Invades the lamina propria, then the muscularis propria (detrusor) | Invasion of muscle is the critical prognostic division |
CLINICAL PEARL
- Muscle invasion is the single most important fact about a bladder tumour.
- Non-muscle-invasive disease is managed endoscopically with intravesical treatment and surveillance, and most patients keep their bladder.
- Muscle-invasive disease requires radical cystectomy or radiotherapy and carries a far worse prognosis. This is why the resection specimen must include detrusor muscle — a biopsy without it cannot answer the question that matters.
Clinical Features and Investigation
- Painless gross haematuria is the classical presentation, present in about 85%; it is often intermittent, and a single episode demands full investigation
- Frequency, urgency and dysuria suggest carcinoma in situ or a trigonal tumour, and are easily mistaken for infection
- Obstruction of a ureteric orifice causes hydronephrosis and may present as renal impairment
- Cystoscopy with biopsy is the definitive investigation; urine cytology is useful for high-grade tumours and carcinoma in situ, which shed abnormal cells, but often misses low-grade papillary tumours
- CT urography images the upper tracts, which must always be assessed because of the field effect
Applied Aspects
- Painless haematuria in an adult is bladder cancer until proved otherwise — it must never be attributed to infection or to anticoagulation without investigation
- Transurethral resection with intravesical BCG or mitomycin for non-muscle-invasive disease; BCG provokes a local immune response and is particularly effective for carcinoma in situ
- Lifelong cystoscopic surveillance is essential because of the high recurrence rate; this makes bladder cancer among the most expensive cancers to manage per patient
- Radical cystectomy with urinary diversion, or radical radiotherapy, for muscle-invasive disease, with neoadjuvant chemotherapy
- Smoking cessation reduces the risk of recurrence as well as of the first tumour, and is part of treatment rather than merely advice
- In India, chronic catheterisation, stones and infection make squamous cell carcinoma relatively more common than in Western series
All questions in Renal & Genitourinary Pathology
- Q1Describe the mechanisms of glomerular injury. Differentiate the nephritic from the nephrotic syndrome and add a note on rapidly progressive glomerulonephritis. ★
- Q2Define nephrotic syndrome. Describe its pathophysiology, causes, morphology and complications. ★
- Q3Classify acute kidney injury. Describe acute tubular necrosis with its types, morphology and clinical course. ★
- Q4Describe acute and chronic pyelonephritis. Add a note on chronic kidney disease and its systemic consequences. ★
- Q5Classify renal tumours. Describe renal cell carcinoma and Wilms tumour. ★
- SN1Describe acute post-streptococcal glomerulonephritis with its pathogenesis and morphology. ★
- SN2Classify renal calculi. Describe their pathogenesis and complications. ★
- SN3Classify cystic diseases of the kidney. Describe adult polycystic kidney disease. ★
- SN4Differentiate benign prostatic hyperplasia from carcinoma of the prostate. ★
- SN5Describe carcinoma of the urinary bladder with its aetiology, morphology and clinical features. ★
- SN6Describe diabetic nephropathy with its pathogenesis, morphology and clinical stages. ★
- SN7Classify testicular tumours. Differentiate seminoma from non-seminomatous germ cell tumours.